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Edited by Hans EklundAbstract Cone snail venom is a rich source of bioactives, in
particular small disulﬁde rich peptides that disrupt synaptic
transmission. Here, we report the discovery of conomap-Vt
(Conp-Vt), an unusual linear tetradecapeptide isolated from
Conus vitulinus venom. The sequence displays no homology to
known conopeptides, but displays signiﬁcant homology to pep-
tides of the MATP (myoactive tetradecapeptide) family, which
are important endogenous neuromodulators in molluscs, annelids
and insects. Conp-Vt showed potent excitatory activity in several
snail isolated tissue preparations. Similar to ACh, repeated doses
of Conp-Vt were tachyphylactic. Since nicotinic and muscarinic
antagonists failed to block its eﬀect and Conp-Vt desensitised
tissue remained responsive to ACh, it appears that Conp-Vt con-
tractions were non-cholinergic in origin. Finally, biochemical
studies revealed that Conp-Vt is the ﬁrst member of the MATP
family with a D-amino acid. Interestingly, the isomerization of
L-Phe to D-Phe enhanced biological activity, suggesting that this
post-translational modiﬁed conopeptide may have evolved for
prey capture.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Cone snails are predatory marine gastropods that rapidly
immobilise their prey by injecting potent venom peptides
through a harpoon-like radula tooth [1]. Most conopeptides
are antagonists, blocking receptors of key physiological role
with high aﬃnity and speciﬁcity. The few agonist conotoxins
identiﬁed typically show homology to endogenous neurotrans-
mitters. While only a relatively small number of conotoxins
have been fully characterised, several are now widely used as
research tools and a few are being developed as therapeutics
[2]. Conus venom peptides are usually highly constrained struc-
tures, typically containing 1–3 disulﬁde bonds [3]. Here we re-
port the isolation of a small linear excitatory peptideAbbreviations: ACN, acetonitrile; Conp-Vt, conomap-Vt; MATP,
myoactive tetradecapeptide; TFA, triﬂuoroacetic acid
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doi:10.1016/j.febslet.2006.06.011containing a D-amino acid from Conus vitulinus venom. This
novel peptide, named conomap-Vt (Conp-Vt), showed no
homology to previously discovered conopeptides, but had up
to 65% sequence identity with ‘‘myoactive tetradecapeptides’’
(MATPs), found in non-venomous molluscs, annelids and in-
sects [4]. MATPs are fourteen amino acid long peptides with
excitatory actions in invertebrate smooth muscles. However,
their precise mode of action has not been determined.
Biochemical studies revealed the presence of a D-phenylala-
nine in Conp-Vt at position 2. A D-amino acid is a rare
post-translational modiﬁcation, even amongst the highly
post-translationally modiﬁed Conus peptides [5]. Indeed, only
4 conopeptides containing a D-amino acid have been isolated
to date, with no obvious pattern in the position of the isomer-
ised residue, suggesting the presence of several isomerases in
cone snail venoms [6–9]. D-amino acid peptides have also been
found in other venoms, including those from spiders and frogs
and an isomerase has been characterised from the American
funnel-web spider Agelenopsis aperta venom and from Bombi-
nae frog skin secretions [10,11]. Recently, several D-amino acid
containing peptides were also identiﬁed in the venom of a
mammal, Ornithorhynchus anatinus the Australian platypus,
along with evidence for the presence of an isomerase [12–14].
Clearly, the isomerization of amino acids is more widely dis-
tributed than once thought, but the role of such modiﬁcation
is not well understood. We propose that L to D isomerization
in Conp-Vt contributes to enhanced activity of the venom.2. Materials and methods
2.1. Materials
Boc protected amino acids and reagents used during chain assembly
and HPLC puriﬁcation (dimethylformamide, dichloromethane, aceto-
nitrile (ACN) and triﬂuoroacetic acid (TFA)) were peptide synthesis
grade and purchased from Auspep (Melbourne, Australia) and Nova-
biochem (San Diego, CA). MBHA-NH2 resin was obtained from Ap-
plied Biosystems (Foster City, CA). Drugs were from Sigma (St. Louis,
MO, USA). D-phenylalanine was a gift from Peter Cassidy (Institute
for Molecular Bioscience, Australia).
2.2. Animals
Male Wistar rats (150–250 g) sourced from the Central Animal
Breeding House, The University of Queensland (St. Lucia, Brisbane,
Australia) were killed by 100% CO2 followed by cervical dislocation
before dissection of tissues. Pomacea bridgesi snails (5–15 g) purchased
from a local pet shop (Westside Pets & Aquarium, Brisbane, Australia)
were maintained for at least a week before use in an aerated aquaria
containing dechlorinated tap water (neutral pH; ambient temperature;
12:12 dark:light cycle). All experiments involving the use of animals
were conducted with the approval of the University of Queensland
Animal Experimentation Ethics Committee.ation of European Biochemical Societies.
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Specimens of C. vitulinus of the C. planorbis/vitulinus complex
(Fig. 1A inset shows the C. vitulinus form of this presently not well-
deﬁned complex) were collected from the Great Barrier Reef, Queens-
land, Australia. The venom ducts were dissected and venom extract
prepared as previously described [15]. A total of 80 · 1 min fractions
were collected and stored at 4 C until further use. Conp-Vt was puri-
ﬁed from fraction 27 on analytical RP-HPLC (C18 Phenomenex col-
umn) with a linear gradient of solution B (B: 90% ACN, 0.45%
TFA; A: 0.5% TFA). The ﬂow rate was 1 mL/min and absorbance
monitored at 214 nm. Pure peptide (20 pmol) was submitted to the
Biomolecular Research Facility (Newcastle, NSW, Australia) for
N-terminal sequencing.Fig. 1. Analytical RP-HPLC chromatograms. (A) C. vitulinus crude
venom fraction 27. Inset shows a C. vitulinus shell. (B) Puriﬁed native
Conp-Vt. (C) Puriﬁed synthetic L-Phe-Conp-Vt. This synthetic version
of Conp-Vt eluted 5 min earlier than native Conp-Vt on the same C18
column under the same conditions, indicating the presence of a post-
translational modiﬁcation in native Conp-Vt. Monoisotopic masses
are indicated.2.4. Mass spectrometry
Molecular mass analyses of the puriﬁed active venom peptide, syn-
thetic isomers, and LC–MS analysis on crude venom and digested pep-
tides were performed on a PESciex API QSTAR Pulsar instrument
over m/z 400–2000. LC conditions were: Phenomenex 5 lm C18
2.1 · 150 mm column eluted with 0–60% B in 60 min, (A: 0.1% formic
acid; B: 90% ACN, aqueous 0.09% formic acid) at 300 lL/min. Data
were analysed using Analyst software.
2.5. Synthesis and puriﬁcation of peptides
All peptides were assembled in high yield using Boc chemistry with
in situ neutralisation protocols on a 0.5 mmol scale [16]. Semiprepara-
tive chromatographic separation of crude peptides from HF cleavage
was achieved on a C18 Phenomenex RP-HPLC column using a linear
gradient from 0% to 60% B (A: 0.5% TFA; B: 0.45% TFA, 90%
ACN) in 60 min. The UV absorbance of the eluant was monitored
at 220 nm, and collected fractions were analysed by electrospray ioni-
sation mass spectrometry (ES-MS). Pure fractions as determined by
analytical RP-HPLC containing the correct mass for each peptide were
pooled and lyophilised. Peptide aliquots were prepared in MilliQ water
and stored at 4 C.
2.6. Trypsin digestion
Pure native and synthetic peptides were digested with trypsin enzyme
(Trypsin TPCK treated from bovine pancreas, Sigma). Peptides and
trypsin were dissolved in ammonium bicarbonate buﬀer (pH 8.5) to
a concentration of  1 mg/mL. Trypsin was added to a 300 lL sample
of peptide (ratio 1:50) and placed in an oven at 37 C. After 2 h and
24 h, 50 lL aliquots of the digest were injected in a Phenomenex C18
analytical RP-HPLC column. The peptides were eluted using a linear
gradient of solution B (90% ACN; 0.45% TFA). The ﬂow rate was
1 mL/min and absorbance monitored at 214 nm. Digest products were
identiﬁed through LC–MS.
2.7. Bioassays
Conp-Vt was tested for biological activity on molluscan and
mammalian isolated tissue preparations. In vitro preparations were
mounted in 5 mL isolated organ baths containing a physiological
salt solution (speciﬁed below), which was bubbled with carbogen
(95% O2 and 5% CO2). Preparations were equilibrated in the or-
gan bath for at least 30 min before addition of drugs. Responses
were measured isometrically via a Grass force displacement trans-
ducer (FTO3) and recorded on a MacLab system (ADInstruments,
Castle Hill, NSW, Australia). When required, electrical ﬁeld-stimu-
lation was generated with a Grass S44 stimulator (Quincy, MA,
USA).
The left and right rat atria were isolated, bisected and mounted
onto electrodes or tissues holders, respectively, under 0.75 g resting
tension in organ baths containing Tyrodes solution (composition in
mM: 137 NaCl, 2.7 KCl, 1.4 CaCl2, 0.5 MgCl2, 12 NaHCO3, 0.4
NaH2PO4 and 5.6 D-glucose) maintained at 37 C. The left atrium
was electrically stimulated (7–12 V, 5 ms duration, 2 Hz). The iso-
lated rat ileum was dissected into segments (2 cm) and mounted onto
tissue holders in organ baths containing Tyrodes solution under 0.4 g
resting tension at 34 C. Ileal contractions induced by 10 lM ACh
was used to deﬁne the maximal tissue response and any changes
to this response at the end of each experiment. Tissues were exposed
to 1 lM of each peptide. A recovery period of 3–10 min after pep-
tide or drug addition as well as after washes was allowed between
experiments.
Adult snails (P. bridgesii) were dissected on a sylgard petri dish in
snail ringer (composition in mM: 80 NaCl, 4 KCl, 10 CaCl2, 5 MgCl2,
10 TRIS, 5 glucose; pH 7.4). The whole buccal mass was removed with
cerebral ganglion and mounted onto a tissue holder at 0.6 g resting
tension in organ baths containing the snail ringer. Other snail tissues,
including 1 cm section of crop, penis retractor and foot muscles,
were mounted as described for the buccal mass. The contraction in-
duced by 100 lM ACh was used as a positive control (100% maximal
response) and applied at the beginning and end of each experiment.
Responses to the peptide and its analogues were expressed as a per-
centage of the response induced by 100 lMACh. Tachyphylaxis of tis-
sues to Conp-Vt or ACh was determined by repeat application to the
tissue (without washing between additions) until no further response
was observed.
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Data analysis was performed with a one-way analysis of variance
(ANOVA) followed by a Bonferroni-corrected multiple t test using
GraphPad Prism 4.0. Values of P < 0.05 were considered signiﬁcant.
Data were expressed as means ± S.E.M.3. Results and discussion
3.1. Isolation and sequencing of Conp-Vt
Conp-Vt was isolated from the crude venom of C. vitulinus
as a major peak at fraction 27 of a semipreparative C18 frac-
tionation. The peptide was puriﬁed to homogeneity on RP-
HPLC using a linear gradient of ACN (Fig. 1A and B). Mass
spectrometry established a monoisotopique mass of
1488.86 Da that was unchanged after TCEP reduction. This
result suggesting that the peptide contained no disulﬁde bonds
was subsequently conﬁrmed by the Edman sequence,
AFVKGSAQRVAHGY. The calculated mass (1489.77 Da)
was consistent with an amidated C-terminal, a common
modiﬁcation in Conus peptides [5].
This novel sequence had no homology to known conopep-
tides. However, a BLAST search using the full-length sequence
revealed high similarity with a family of MATP from molluscs
and annelids, and signiﬁcant homology with a family of peptide
hormones from insects (Table 1). Given its similarity to
MATPs, we named this C. vitulinus venom peptide conomap-
Vt (Conp-Vt). All peptides of theMATP family induce contrac-
tions in mollusc, annelid or insect isolated muscle preparations
[17]. Conp-Vt had 65% sequence identity with a Lymnaea
peptide MATP-Ls [18]. Interestingly, while this endogenous
peptide from Lymnaea can modulate the activity of various
peripheral muscles, it is found in the nervous system in high
quantity, suggesting that MATP-Ls is a neuropeptide that
might be produced in the CNS [17]. In addition, tissue localisa-
tion of a related peptide (ETP) from the worm Eisenia foetida
revealed a high immunoreactivity in the CNS and digestive
tract including oesophagus and intestine, while other tissues
including the body wall muscles, sexual organs and nephridia




Conus vitulinus AFVKGSAQRVAHGY* Conomap-Vt
(Conp-Vt)
Lymnaea stagnalis GFRANSASRVAHGY* Lymnaea MATP
(MATP-Ls)
Achatina fulica GFRQDAASRVAHGY* Achatina MATP1
Achatina fulica GFRGDAASRVAHGF* Achatina MATP2
Fusinus ferrugineus GFRMNSSNRVAHGF* Fusinus MATP
Annelida
Eisenia foetida GFKDGAADRISHGF* ETP
Pheretima vittate GFRDGSADRISHGF* PTP
Arthropoda
Aedes aegypti APFR-NSEMMTARGF*
Manduca sexta GFK-NVEMMTARGF* Allatotropin
Locusta migratoria GFK-NVALSTARGF* Lom-AG-MT I
* indicates an amidated C-terminal. Underlined residue indicates a
D-amino acid. Sequences of the peptides are from [17] and references
therein.tus of cone snails is thought to have evolved from digestive or-
gans [20], which may explain the origin of Conp-Vt in the
venom.
3.2. Conp-Vt contains a D-amino acid
Conp-Vt and MATP-Ls peptides were synthesised in high
yield using Boc chemistry. MATP-Ls peptide was chosen for
comparative studies because of its high sequence identity
(65%) with Conp-Vt and its established biological activity
in mollusc tissues. Unexpectedly, analytical RP-HPLC chro-
matograms revealed that synthetic Conp-Vt did not co-elute
with the native peptide (Fig. 1C), suggesting that a post-trans-
lational modiﬁcation may be present in Conp-Vt. Since both
synthetic and native peptides exhibit the same mass, the pres-
ence of a D-amino acid in native Conp-Vt was suspected. To
further explore the possibility that a D-amino acid was present
in Conp-Vt and to start to determine its position in the se-
quence, both native and synthetic peptides were enzymatically
digested and the products analysed using RP-HPLC and LC–
MS. Conp-Vt possesses one arginine and one lysine allowing
trypsin digestion to produce 5 diﬀerent peptide fragments
(Table 2). In theory, peptide fragments of the native Conp-
Vt that contain a D-amino acid will display a diﬀerent elution
time compared to the synthetic peptide fragments, while those
without a D-amino acid should have identical retention times.
After 2 h of trypsin digestion, the mixture of digested native
and synthetic peptides revealed 4 peaks when injected into ana-
lytical RP-HPLC (Fig. 2A and B). LC–MS identiﬁed fragment
1, 3, 4 and 5, while fragment 2 was not found, indicating that
trypsin was more eﬃcient to cleave after the arginine than after
the lysine. Only fragment 1 and 5 had a diﬀerent elution time in
native and synthetic peptide digests. Therefore, a D-amino acid
was predicted to occur in the ﬁrst 4 residues of the native
peptide.
Other linear molluscan peptides containing a D-amino acid
have a contrasting pattern of epimerisation compared to what
has been found for the Conus peptides (see Section 2.4.). In-
deed, all D-amino acid containing peptides isolated from mol-
luscs other than Conus have incorporated a modiﬁed amino
acid at position 2, regardless of the nature of the amino acid
[4]. Conp-Vt is a small linear peptide that resembles the mol-
luscan peptides shown in Table 3 more than disulﬁde contain-
ing conopeptides possessing D-amino acids. As a consequence,
Conp-Vt was hypothesised to contain a D-amino acid at
position 2.
It is believed that in the precursor gene of D-amino acid con-
taining peptides the D-amino acid is encoded as a L-amino acid
that later undergoes enzyme isomerization [9]. Therefore, it isTable 2







AFVKGSAQRVAHGY* (Parent) 1489.70 1488.79
AFVK- (1) 463.57 463.27
-GSAQRVAHGY* (2) 1044.13 1043.52
-GSAQR- (3) 517.54 517.26
-VAHGY* (4) 544.61 544.27
AFVKGSAQR- (5) 963.10 962.52
* indicates an amidated C-terminal. Arrows indicate the trypsin
cleavage sites.
Fig. 2. Analytical RP-HPLC chromatograms of peptide trypsin
digests. (A) Native Conp-Vt, (B) L-Phe-Conp-Vt analogue and (C)
synthetic Conp-Vt trypsin digests (2 h). After 2 h of trypsin digestion,
the mixture was injected into analytical RP-HPLC. For each peptide, 4
peaks were obtained, corresponding to fragments 1, 3, 4 and 5
(Table 2). Fragments 1 and 5 had elution times that diﬀered between
native and L-Phe-Conp-Vt, suggesting that a D-amino acid was present
at position 1, 2, 3 and/or 4 in the peptide. In contrast, synthetic Conp-
Vt containing a D-phenylalanine in position 2 exhibited the same
elution proﬁle as native Conp-Vt. Monoisotopic masses of each peak
are indicated.
Table 3










* indicates an amidated C-terminal. Underlined residues indicate a
D-amino acid. Sequences of peptides are from [4] and references therein.
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found in the crude venom of C. vitulinus. Accordingly, an
ion extraction over the range 745.2–745.6 Da was performed
on an LC–MS spectrum of C. vitulinus crude venom and 2
peaks separated by 5 min corresponding to the mass of
Conp-Vt (MH2+ = 745.4 Da) were identiﬁed (data not shown).
However, the L form (assumed to be the early eluting peak)
represented only 0.6% of the D form, indicating that the
enzyme responsible for the epimerisation of Conp-Vt is an
eﬃcient converting enzyme.3.3. Conp-Vt has a D-phenylalanine in position 2
A synthetic Conp-Vt containing a D-phenylalanine in posi-
tion 2 was synthesised as described for the all L peptides. Syn-
thetic D-Phe-Conp-Vt was subjected to the same trypsin
digestion protocol described for the L-Phe-Conp-Vt and native
peptide. After 2 h of digestion, the mixture was injected into
analytical RP-HPLC. The chromatogram revealed an identical
pattern of digestion compared to the native peptide (Fig. 2C).
In addition, synthetic and native Conp-Vt also coeluted.
Therefore, the correct sequence for Conp-Vt is AFVKG-
SAQRVAHGY-NH2, where F is D-phenylalanine. The all
L analogue will be referred to as L-Phe-Conp-Vt.
The L to D isomerization appears to be a rare post-transla-
tional modiﬁcation, even amongst the highly post-translation-
ally modiﬁed Conus peptides. The ﬁrst conopeptides shown to
contain a D-amino acid were the contryphans, discovered in
the venom of Conus radiatus and C. purpurascens [7,8]. The
modiﬁed amino acid was found in position 4 in both peptides.
More recently, 2 novel families of conopeptides containing a
D-amino acid have been identiﬁed [6,9]. First, a large excit-
atory peptide (46 a.a.) isolated from C. radiatus venom and
belonging to the I superfamily was found to have a D-Phe in
position 44 (the second to the last amino acid of the polypep-
tidic chain). Second, two small peptides (8 a.a.) isolated from
the venom of Conus gladiator and Conus mus were found to
have a D-hydroxyvaline in position 6. Therefore, it appears
that the epimerisation in conopeptides occurs at various posi-
tions in the sequence, suggesting the presence of several highly
speciﬁc isomerases in the venom.
3.4. Conp-Vt is a potent and mollusc speciﬁc excitatory peptide
Peptides belonging to the MATP family are known to exert
a concentration-dependent excitatory eﬀect on a variety of
invertebrate tissues [18,19]. Therefore, the biological activity
of Conp-Vt was tested on diﬀerent molluscan muscle prepara-
tions including the isolated buccal mass, crop, penis retractor
muscle and foot. All tissues responded to the application of
Conp-Vt (Fig. 3). Except for the foot muscle, the initial con-
centration of Conp-Vt (10 nM) produced a contraction or en-
hanced existing spontaneous contractions indicating that
Conp-Vt had a potent excitatory eﬀect, particularly on the
buccal mass. Conp-Vt was also tested on the rat isolated left
and right atrium, and rat isolated ileum preparations. No
activity was detected at concentrations up to 1 lM (data not
shown). Hence, the snail isolated buccal mass preparation
was chosen for further pharmacological characterisation.
1 lM Conp-Vt produced a response similar in amplitude to
100 lMACh but this contracture was overlayed with spikes of
Fig. 3. Cumulative additions of Conp-Vt in the snail (A) buccal mass,
(B) crop, (C) foot muscle and (D) penis retractor muscle. Application
of peptide is indicated by the arrowheads, with 1 = 10 nM;
2 = 100 nM; 3 = 1 lM; W = wash. Conp-Vt initiated a contraction in
all tissues tested, with the greatest response observed in the buccal
mass. Vertical bar represents 0.5 g and horizontal bar represents
10 min.
Fig. 4. Non-cumulative additions of ACh and Conp-Vt in the snail
buccal mass. (A) ACh (1 = 10 lM; 2 = 100 lM; 3 = 200 lM;
W = wash) and Conp-Vt (4 = 10 nM; 5 = 100 nM; 6 = 1 lM;
W = wash). Application of drug is indicated by the arrowheads.
Vertical bar represents 0.5 g and horizontal bar 10 min. (B) Concen-
tration–response curve for Conp-Vt in the snail buccal mass
(EC50 = 8 ± 0.25 nM; n = 5). The amplitude of contraction induced
by diﬀerent Conp-Vt doses was normalised to the initial contractile
response to 100 lM ACh (0.92 ± 0.14 g, n = 30).
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tion–response curve for Conp-Vt conﬁrmed the high potency
of this peptide (EC50 = 8 ± 0.25 nM; Fig. 4B).
3.5. Conp-Vt interacts with non-cholinergic receptors
To further study the mechanism of action of Conp-Vt it was
tested for its ability to induce tachyphylaxis. Tachyphylaxis isdeﬁned as the acute loss of response upon repeated stimula-
tions with agonists [21]. Similar to the activity produced by
ACh, Conp-Vt induced tachyphylaxis after a few repeat appli-
cations (Fig. 5A and B). However, while ACh tolerant tissue
failed to generate a Conp-Vt response, Conp-Vt tolerant tissue
still responded normally to ACh (Fig. 5A and B). This result
suggests that Conp-Vt develops tachyphylaxis independent of
cholinergic receptors. To start to dissect the direct and indirect
components of the Conp-Vt contractile response, ACh antag-
onists a-bungarotoxin, d-tubocurarine and atropine were
tested for their ability to block the Conp-Vt induced contrac-
tion. Surprisingly given the lack of response in ACh tolerant
tissue, responses to 100 nM and 1 lM of Conp-Vt were not
modiﬁed (Fig. 5C) following pre-treatment with a high concen-
tration of a mix of all three cholinergic antagonists. However,
responses to ACh were also unmodiﬁed in the presence of these
antagonists (data not shown). Limitations in characterising
cholinergic activity in molluscan isolated preparations are also
highlighted in other studies [22–24], which found inconsisten-
cies in the ability of atropine and d-tubocurarine to antagonise
Fig. 5. Preliminary pharmacological characterisation of Conp-Vt. (A) Tachyphylaxis to (A) ACh and (B) Conp-Vt was achieved by repeated
administration of 100 lM ACh or 1 lM Conp-Vt, respectively (n = 4 each). (C) The eﬀect of cholinergic antagonists on Conp-Vt contractions in the
snail isolated buccal mass. a-Bungarotoxin (1 lM), d-tubocurarine (10 lM) and atropine (10 lM) were added at least 10 min prior to the addition of
Conp-Vt (n = 4). (D) The contractile activity produced by 1 lM of conp-Vt and related peptides. A = MATP-Ls, B = D-Phe-MATP-Ls, C = L-Phe-
Conp-Vt and D = Conp-Vt (n = 4 for each peptide). *P < 0.05 indicating the response was signiﬁcantly diﬀerent to the response produced by A,
B or D.
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MATPs (ETP and PTP) was not aﬀected by atropine [19]. Ta-
ken together, an action of Conp-Vt at non-cholinergic recep-
tors to cause the release of ACh and contraction is
consistent with the antagonist and tachyphylaxis experiments.
3.6. Role of D-phenylalanine in Conp-Vt
The biological activity of Conp-Vt, L-Phe-Conp-Vt and
MATP-Ls were compared in the snail isolated buccal mass
preparation (Fig. 5D). While 1 lM of Conp-Vt and MATP-
Ls produced responses of similar amplitude, 1 lM of L-Phe-
Conp-Vt was less potent. Remarkably, this phenylalanine
residue at position 2 is one of only two absolutely conserved
amino acids in all MATP peptides (Table 1). As Conp-Vt is
the ﬁrst known member to contain a D-amino acid, it was of
interest to determine if a D-phenylalanine could enhance the
activity of other MATP. Synthetic D-Phe-MATP-Ls was
found to be as active as the MATP-Ls peptide (Fig. 5D). Since
a synthetic MATP-Ls peptide was not compared with the
native compound, we cannot rule out the possibility that a
D-Phe-MATP-Ls also occurs in Lymnaea [18]. Conp-Vt is a
major component of the venom of C. vitulinus, suggesting that
this peptide may play an important role in prey capture. In-
deed, 85–90% of all cone snail species including C. vitulinus
prey on worms and molluscs, and a peptide that can disrupt
vital functions such as muscle contraction would constitute
an eﬃcient weapon in prey subjugation and capture. We pro-pose that Conp-Vt has evolved from the cone snail’s own
endogenous MATP peptide for specialised venom use.
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